Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Gastrointestinal 2CNS 2Other hematologic neoplasm 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Multiple Myeloma 4Pancreatic Neoplasms 3Prostatic Neoplasms 2Primary Myelofibrosis 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasm Metastasis 2Myeloproliferative Disorders 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Acute 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hodgkin Disease 2Hematologic Neoplasms 2Glioblastoma 2Colonic Neoplasms 2Breast Neoplasms 2Blast Crisis 2Waldenstrom Macroglobulinemia 1Thrombocytosis 1Thrombocythemia, Essential 1Stomach Neoplasms 1Rectal Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Polycythemia Vera 1Neoplasms, Plasma Cell 1Myelodysplastic-Myeloproliferative Diseases 1

Interventions

Oxaliplatin 2Leucovorin 2Gemcitabine 2Fluorouracil 2Bevacizumab 2Azacitidine 2temsirolimus 1ruxolitinib 1rucaparib 1repotrectinib 1fludarabine 1ceritinib 1cc-486 1abiraterone 1Uncertainty 1Thalidomide 1Temozolomide 1Suspensions 1Sorafenib 1Quality of Life 1Psychosocial Intervention 1Patient Reported Outcome Measures 1Paclitaxel 1Molecular Diagnostic Techniques 1Lenalidomide 1Irinotecan 1Interleukin-2 1Injections 1Immunotherapy 1INCB057643 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Glioblastoma × Fluorouracil × Plasma cell × Clear all
NCT03607643 2018-07-31

A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies

Leaf Vertical Inc.

Phase 1/2 Unknown
160 enrolled
CNSGastrointestinalPlasma cell

Colonic Neoplasms, Gallbladder Neoplasms, Glioblastoma, Liver Neoplasms, Multiple Myeloma, Pancreatic Neoplasms, Rectal Neoplasms

NCT01183663 2016-06-03

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

M.D. Anderson Cancer Center

Phase 1 Completed
180 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryOther hematologic neoplasmPlasma cell

Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Glioblastoma, Melanoma, Multiple Myeloma, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡